Exact Sciences Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
7,000
- Stock Symbol
-
EXAS
- Investments
-
18
- Share Price
-
$53.54
- (As of Tuesday Closing)
Exact Sciences General Information
Description
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
Contact Information
Website
www.exactsciences.comCorporate Office
- 5505 Endeavor Lane
- Madison, WI 53719
- United States
Corporate Office
- 5505 Endeavor Lane
- Madison, WI 53719
- United States
Exact Sciences Timeline
Exact Sciences Stock Performance
As of 08-Jul-2025, Exact Sciences’s stock price is $53.54. Its current market cap is $10.1B with 189M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $53.54 | $52.48 | $39.97 - $72.83 | $10.1B | 189M | 2.98M | -$5.51 |
Exact Sciences Financials Summary
As of 31-Mar-2025, Exact Sciences has a trailing 12-month revenue of $2.83B.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 9,758,084 | 12,136,699 | 15,206,581 | 10,574,335 |
| Revenue | 2,828,128 | 2,758,867 | 2,499,766 | 2,084,279 |
| EBITDA | (788,526) | (789,328) | 29,283 | (421,105) |
| Net Income | (1,019,844) | (1,028,857) | (204,149) | (623,506) |
| Total Assets | 5,711,073 | 5,928,139 | 6,471,334 | 6,226,873 |
| Total Debt | 2,521,284 | 2,754,758 | 2,554,725 | 2,446,871 |
Exact Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Exact Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Exact Sciences Comparisons
Industry
Financing
Details
Exact Sciences Competitors (35)
One of Exact Sciences’s 35 competitors is Myriad Genetics, a Corporation company based in Salt Lake City, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Myriad Genetics | Corporation | Salt Lake City, UT | ||||
| Guardant Health | Formerly VC-backed | Palo Alto, CA | ||||
| Veracyte | Formerly VC-backed | South San Francisco, CA | ||||
| Foundation Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Adela | Venture Capital-Backed | Foster City, CA |
Exact Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Exact Sciences Patents
Exact Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023383369-A1 | Compositions and methods for detecting urological cancer | Pending | 17-Nov-2022 | ||
| CA-224823-S | Part of sample collector device | Active | 26-Oct-2022 | ||
| CA-224824-S | Part of sample collector device | Active | 26-Oct-2022 | ||
| CA-224825-S | Part of sample collector device | Active | 26-Oct-2022 | ||
| AU-2023367203-A1 | Sample collection device | Pending | 26-Oct-2022 | A61B10/0038 |
Exact Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Exact Sciences Investments & Acquisitions (18)
Exact Sciences’s most recent deal was a Merger/Acquisition with Resolution Bioscience for . The deal was made on 12-Sep-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Resolution Bioscience | 12-Sep-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| Haystack Oncology | 16-Nov-2022 | Early Stage VC | Diagnostic Equipment | ||
| OmicEra Diagnostics | 05-Nov-2022 | Merger/Acquisition | Biotechnology | ||
| PreventionGenetics | 31-Dec-2021 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| PFS Genomics | 03-May-2021 | Merger/Acquisition | Diagnostic Equipment |
Exact Sciences ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
20.85 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile
Pharmaceuticals
Industry
of 847
Rank
Percentile
Biotechnology
Subindustry
of 368
Rank
Percentile
Exact Sciences Exits (2)
Exact Sciences’s most recent exit was on 16-Nov-2022 from Haystack Oncology. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Haystack Oncology | 16-Nov-2022 | Completed |
|
||
| Renovia | 29-Apr-2021 | Later Stage VC | Completed |
|
Exact Sciences Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Base Genomics | Oxford, United Kingdom | 2018 | |
| PreventionGenetics | Marshfield, WI | 2004 |
Exact Sciences FAQs
-
When was Exact Sciences founded?
Exact Sciences was founded in 1995.
-
Where is Exact Sciences headquartered?
Exact Sciences is headquartered in Madison, WI.
-
What is the size of Exact Sciences?
Exact Sciences has 7,000 total employees.
-
What industry is Exact Sciences in?
Exact Sciences’s primary industry is Diagnostic Equipment.
-
Is Exact Sciences a private or public company?
Exact Sciences is a Public company.
-
What is Exact Sciences’s stock symbol?
The ticker symbol for Exact Sciences is EXAS.
-
What is the current stock price of Exact Sciences?
As of 08-Jul-2025 the stock price of Exact Sciences is $53.54.
-
What is the current market cap of Exact Sciences?
The current market capitalization of Exact Sciences is $10.1B.
-
What is Exact Sciences’s current revenue?
The trailing twelve month revenue for Exact Sciences is $2.83B.
-
Who are Exact Sciences’s competitors?
Myriad Genetics, Guardant Health, Veracyte, Foundation Medicine, and Adela are some of the 35 competitors of Exact Sciences.
-
What is Exact Sciences’s annual earnings per share (EPS)?
Exact Sciences’s EPS for 12 months was -$5.51.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
